NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Kansai Nerolac Paints Research Report

Summary

Kansai Nerolac Paints (KNPL) is expected to see increased focus on the Industrial paints/Auto paints segment, with a revenue share increase in the medium term. The company attributes this growth to sustained high growth in Automotive Paints, Auto refinishes, Powder coatings, and strong traction in emerging segments.

Business Strategy

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

The management highlighted the importance of industrial paints, driven by innovation, policy tailwinds, and Kansai's technological edge. The decorative business is expected to recover in the medium term, despite high competitive intensity. KNPL remains confident of stability in the next 1-2 quarters, driven by an improving demand scenario.

Outlook

We expect KNPL to grow at a 7.9% EPS Compound Annual Growth Rate (CAGR) over FY26-28. The company is currently trading at 20.7x FY28 EPS, factoring in most negatives. However, the stock lacks immediate triggers. As a result, we maintain a Retain Accumulate rating with a Target Price (TP) of Rs248, unchanged from our previous recommendation.

Investor Takeaway

Investors should maintain a buy rating for Kansai Nerolac Paints with a target of ₹248.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.